CFT8634

· C4 Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CFT8634, covering 2024-12-17 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors [Phase 1]

See pricing